Top 6 Asthma treatment startups in USA
Nov 14, 2025
Like
24
1
Funding: $250M
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
2
Funding: $207M
Triveni Bio focuses on the identification of novel disease by combining human genetics and precision medicine.
Triveni Bio focuses on the identification of novel disease by combining human genetics and precision medicine.
3
Funding: $185.9M
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
4
Funding: $33.2M
VIDA is a leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, reproducible and quantitative
VIDA is a leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, reproducible and quantitative
5
Funding: $23.3M
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
6
Funding: $16.8M
Cohero developed a connected spirometer to assess lung function and medication adherence in asthma and COPD patients. It was designed to be a clinical grade medical device to function as a barometer for lung function. It also produced a patient-facing app that helps users track their data.
Cohero developed a connected spirometer to assess lung function and medication adherence in asthma and COPD patients. It was designed to be a clinical grade medical device to function as a barometer for lung function. It also produced a patient-facing app that helps users track their data.
★
See also:
